Additionally, we also found that the rs1263790 G allele of METTL3 had a protective effect of HBV‐HCC OS, suggesting the genetic variants of METTL3 might serve as a potential tumour biomarker in HBV‐HCC. Here, METTL3 is linked to hepatocellular carcinoma.